68 related articles for article (PubMed ID: 7558206)
1. Prognostic significance of DNA index by flowcytometry in acute lymphoblastic leukaemia.
Parikh PM; Ashokkumar MS; Pai SK; Redkar A; Chopra HK; Barbhaya SA; Gopal R; Mittra I; Advani SH
Indian J Med Res; 1995 Jul; 102():24-7. PubMed ID: 7558206
[TBL] [Abstract][Full Text] [Related]
2. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
[TBL] [Abstract][Full Text] [Related]
3. DNA Index in childhood acute lymphoblastic leukaemia: a karyotypic method to validate the flow cytometric measurement.
Rachieru-Sourisseau P; Baranger L; Dastugue N; Robert A; Geneviève F; Kuhlein E; Chassevent A
Int J Lab Hematol; 2010 Jun; 32(3):288-98. PubMed ID: 19793113
[TBL] [Abstract][Full Text] [Related]
4. [DNA index determined by flow cytometry in children with acute lymphoblastic leukemia as an additional diagnostic and prognostic element].
Sikorska-Fic B; Wasik M; Rokicka-Milewska R
Wiad Lek; 1998; 51 Suppl 4():103-6. PubMed ID: 10731951
[TBL] [Abstract][Full Text] [Related]
5. [A prognostic factor in childhood acute lymphoblastic leukemia: implication of cellular DNA contents. Children's Cancer and Leukemia Study Group].
Katano N; Tsurusawa M; Kawai S; Fujimoto T
Rinsho Ketsueki; 1989 Jul; 30(7):943-50. PubMed ID: 2810797
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
7. Presenting features and treatment outcome of adolescents with acute lymphoblastic leukemia.
Santana VM; Dodge RK; Crist WM; Rivera GK; Look AT; Behm FG; Raimondi SC; Pui CH
Leukemia; 1990 Feb; 4(2):87-90. PubMed ID: 2304360
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
[TBL] [Abstract][Full Text] [Related]
9. [Incidence and distribution of t(12;21) in prognostic groups of pediatric acute lymphoblastic leukemia].
Lacza A; Jáksó P; Kereskai L; Szuhai K; Méhes G; Pajor L
Orv Hetil; 2000 Jul; 141(27):1495-500. PubMed ID: 10943106
[TBL] [Abstract][Full Text] [Related]
10. [Study of antigenic profile of blasts in acute lymphoblastic leukemia: flow cytometric analysis of 152 cases].
Jmili NB; Souguir S; Yacoub S; Khelif A; Kortas M
Ann Biol Clin (Paris); 2009; 67(5):543-51. PubMed ID: 19789126
[TBL] [Abstract][Full Text] [Related]
11. Response rate of Pakistani children with acute lymphoblastic leukaemia to Medical Research Council acute lymphoblastic leukaemia 97 chemotherapy protocol.
Idris M; Farid J; Sarwar J; Ahmed S; Wiqar MA; Badsha S
J Ayub Med Coll Abbottabad; 2010; 22(3):8-11. PubMed ID: 22338406
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of chromosome analysis in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
Hyakuna N; Kaneko Y; Katano N; Iwai T; Nagata T; Sakashita K; Takeda O; Tanaka A; Azuma H; Sekine I; Fujimoto T
Rinsho Ketsueki; 2000 Jul; 41(7):576-84. PubMed ID: 11020981
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
14. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology.
Duque RE; Andreeff M; Braylan RC; Diamond LW; Peiper SC
Cytometry; 1993; 14(5):492-6. PubMed ID: 8354121
[No Abstract] [Full Text] [Related]
15. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
[TBL] [Abstract][Full Text] [Related]
16. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
17. [Use of flow cytometry in the diagnosis of acute leukemias in childhood].
Starý J; Sokol L; Hausner P; Hrodek O; Sedmihorská J; Volejníková J; Vlachynský M
Cas Lek Cesk; 1992 Jun; 131(12):364-7. PubMed ID: 1504986
[TBL] [Abstract][Full Text] [Related]
18. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
19. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
20. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
